At BeiGene, we are in a mission to help cancer patients by discovering and developing new drugs and treatments through cutting-edge science.

We are committed in partnering with academia, biotech and pharmaceutical companies around the world to discover innovative products for improved patient treatment.

We mainly focus on all kinds of solid tumours and haematological cancers, keeping in mind the safety profile, high standard of quality, state of the art scientific research and services.

We design and innovate new drugs against solid tumours and haematological cancers with an advancing pipeline of novel small molecules and monoclonal antibodies against cancer and combination solutions to create meaningful and lasting impact on cancer patients.

To find out more about partnering, science and pipeline, and other information provided by BeiGene, please follow the link